BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Global Biodefense - ECPv6.18.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://globalbiodefense.com
X-WR-CALDESC:Events for Global Biodefense
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Lisbon
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:WEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:WET
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:WEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:WET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:WEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:WET
DTSTART:20231029T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20210314T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20211107T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20220313T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20221106T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20230312T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20231105T070000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20230312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20231105T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20240310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20241103T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20210101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Dublin
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:IST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:IST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:IST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20231029T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Asia/Singapore
BEGIN:STANDARD
TZOFFSETFROM:+0800
TZOFFSETTO:+0800
TZNAME:+08
DTSTART:20210101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Denver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20220313T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20221106T080000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20230312T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20231105T080000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20240310T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20241103T080000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Rome
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20241027T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220404T110000
DTEND;TZID=America/New_York:20220404T170000
DTSTAMP:20220321T200058Z
CREATED:20220321T200058Z
LAST-MODIFIED:20220321T200058Z
UID:54494-1649070000-1649091600@globalbiodefense.com
SUMMARY:Public Workshop on Use of Population Descriptors in Genomics Research
DESCRIPTION:The second meeting of the Committee on Use of Race\, Ethnicity\, and Ancestry as Population Descriptors in Genomics Research will be held on April 4 and April 7\, 2022. \nAs part of this workshop\, the committee request public comment on the current use of population descriptors such as race\, ethnicity\, ancestry\, etc. in genomics research and how the use of population descriptors could be improved upon in the future. \nThe agenda will be available on the event webpage. \nThe committee requests public comments as part of this workshop. The committee would like to hear from researchers\, advocates\, and any other interested stakeholders on how population descriptors are currently being used effectively in genomics research\, how they could be improved\, and what systems might be used effectively in the future. \nThe committee will invite a few authors representing a sample of the submissions to present their comments at the workshop on April 4th. If you wish to be considered as a speaker at this workshop\, please submit your comment by March 23rd. Authors of submission submitted after March 23rd may also be considered to be speakers at the workshop in the summer. \nClick here to learn more and submit your comment.
URL:https://globalbiodefense.com/event/public-workshop-on-use-of-population-descriptors-in-genomics-research/
CATEGORIES:Conference
LOCATION:https://bit.ly/nasem-genomics
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220404T130000
DTEND;TZID=America/New_York:20220404T140000
DTSTAMP:20220906T194716Z
CREATED:20220327T183107Z
LAST-MODIFIED:20220906T194716Z
UID:54592-1649077200-1649080800@globalbiodefense.com
SUMMARY:Deterring Russia's Biological\, Chemical and Nuclear Threat
DESCRIPTION:Biological\, Chemical\, and Nuclear Weapons: Can the West deter Russia from using them? \nThe National Committee on American Foreign Policy (NCAFP) will the event 4 April 2022 from 1:00 – 2:00 Eastern. \nOn February 27 President Vladimir Putin ordered Russia’s nuclear deterrent forces to be put on high alert\, sending shockwaves through Europe and the international community. As the conflict has drawn on longer than anticipated\, U.S. intelligence officials have warned of Putin’s “back against the wall” escalations. More recently\, on March 11th\, Russian propaganda outlets accused the U.S. of funding and harboring biological weapons facilities in Ukraine. Although these claims are false\, the Kremlin’s misinformation campaign has signaled to Russia-watchers and intelligence officials that Putin is fabricating information and messaging to justify his own intention to authorize chemical\, biological\, or a possible small tactical nuclear weapon. \nHow can the U.S.\, Europe Union\, and Allies brace for a possible Russian chemical or biological weapons attack in Ukraine? Are there lessons the U.S. has learned from the failure to respond to chemical weapons use in Syria in 2013? How might Western countries prevent\, mitigate\, or respond to such an attack? How could NATO\, the U.S.\, and Allies respond while trying to prevent further escalations? \nTo help answer these questions and many more\, please join the Honorable Andy Weber\, Senior Fellow at the Council on Strategic Risks’ and former Assistant Secretary of Defense for Nuclear\, Chemical and Biological Defense Programs\, and Mr. Ankit Panda\, Stanton Senior Fellow in the Nuclear Policy Program at Carnegie Endowment for International Peace. The program will be moderated by Ambassador (ret.) Susan M. Elliott\, President & CEO of the NCAFP. \nPlease visit the NCAFP’s Deterring Russia’s Biological\, Chemical and Nuclear Threat event page to register. \n 
URL:https://globalbiodefense.com/event/deterring-russias-biological-chemical-and-nuclear-threat/
CATEGORIES:Conference
LOCATION:https://us02web.zoom.us/webinar/register/WN_Sco1z-VkS5yuV4Zr-801Vw
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220418
DTEND;VALUE=DATE:20220520
DTSTAMP:20220323T164348Z
CREATED:20220323T164348Z
LAST-MODIFIED:20220323T164348Z
UID:54551-1650240000-1653004799@globalbiodefense.com
SUMMARY:ICE\, ICE\, Data: Using NICEATM’s Integrated Chemical Environment to Support Chemical Evaluations
DESCRIPTION:Join us April 18-19 for a special training session featuring experts from the NTP Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM). \nNICEATM’s Integrated Chemical Environment is a free online suite that houses curated toxicity and physicochemical property data\, integrated into a variety of tools to analyze and visualize chemical data. These tools provide data access adhering to FAIR principles: data that is Findable\, Accessible\, Interoperable\, and Reusable for chemical characterization\, PBPK\, IVIVE\, and more! \nAt this two-day event\, you will learn directly from NICEATM developers how to use the Integrated Chemical Environment and have the opportunity to have your questions answered in the Q&A session. For your convenience\, a printable agenda is available for download below. You will receive session materials through the Zoom Webinar platform ahead of the event. Recordings and other materials will be made available shortly after the sessions. Registration is free\, but required to attend.
URL:https://globalbiodefense.com/event/ice-ice-data-using-niceatms-integrated-chemical-environment-to-support-chemical-evaluations/
CATEGORIES:Conference,Training
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2022/03/NURA-ICE.jpg
LOCATION:https://us06web.zoom.us/webinar/register/WN_UK_LklHqT5iGGtBgCy_Cjg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220423
DTEND;VALUE=DATE:20220427
DTSTAMP:20220421T013722Z
CREATED:20220420T234848Z
LAST-MODIFIED:20220421T013722Z
UID:54824-1650672000-1651017599@globalbiodefense.com
SUMMARY:32nd EECMID - European Congress of Clinical Microbiology & Infectious Diseases
DESCRIPTION:The 32nd European Congress of Clinical Microbiology & Infectious Disease (ECCMID) will take place as a hybrid event both online and in Lisbon\, Portugal on 23 – 26 April 2022. \nThe event brings together experts from many fields to present their latest findings\, guidelines and experiences to an audience of over 14\,000 colleagues. This year\, the congress will feature a hybrid format to facilitate an onsite and online experience for attendees allowing for remote and face-to-face opportunities to take part in the multifaceted programme. \nHighlighted programme topics include: \n\nAdvances in Clostridioides difficile infection outbreak prevention and control\nDigging in the molecular epidemiology of MDR Enterobacterales\nNovel insights into herpetic infections\nOpportunistic infections of the central nervous system\nFungal infections from head to toes\nPathogenic Escherichia coli: the emergence of cross pathotypes from the genomic continuum\nOne Health and mycology: what are the significant and potential interactions between agriculture and human health?\nLeveraging the host response to acute infection to create new diagnostic and prognostic tools\nNew insights into phages: current challenges and future developments\nHow to apply Digital PCR in clinical microbiology\nmRNA science: a paradigm shift to address unmet medical needs\nA post-COVID syndrome: a never-ending story\nPathogens and the microbiome: antibiotics at the crossroads\nRespiratory viral infections in hospital settings\nRole of monoclonal antibodies (mAbs) in the evolution of COVID-19 treatment\nNew perspectives on Schistosomiasis in Europe\nShould you manage bloodstream infection differently in immunocompromised patients?\nGenomics underpin the clinical and public health management of tuberculosis\nCOVID-19 diagnostics: new and newer\nNovel predictive and diagnostic tools in severe viral and bacterial infections\nModelling host-pathogen interaction in persistent infections\nRapid diagnostic tools inform prudent antibiotic use\n\nPlease visit the European Congress of Clinical Microbiology & Infectious Diseases 2022 meeting page to register.
URL:https://globalbiodefense.com/event/32nd-eecmid-european-congress-of-clinical-microbiology-infectious-diseases/
LOCATION:Congrex Switzerland\, Reinacherstrasse 131\, Basel\, CH-4053\, Switzerland
CATEGORIES:Conference
ORGANIZER;CN="European Society of Clinical Microbiology and Infectious Diseases (ESCMID)":MAILTO:info@escmid.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220501
DTEND;VALUE=DATE:20220505
DTSTAMP:20220420T225637Z
CREATED:20210925T162254Z
LAST-MODIFIED:20220420T225637Z
UID:49837-1651363200-1651708799@globalbiodefense.com
SUMMARY:2022 ASM Clinical Virology Symposium
DESCRIPTION:The 2022 ASM Clinical Virology Symposium will be held 1-4 May 2022 in West Palm Beach\, Florida and with virtual participation options. \nThe event brings together top biomedical scientists\, physicians and laboratorians to discuss the latest in diagnostic virology\, vaccine development\, molecular diagnostics and more. \nASM will also include a virtual component providing access to the scientific program and accommodating those who are unable or do not wish to attend in-person. Get details on the digital experience. \nThe symposium is intended for physicians\, laboratory directors\, laboratory professionals\, technicians\, laboratory supervisors\, technologists and other health care professionals with an interest in the latest developments in clinical and diagnostic virology. \nHighlighted session topics include: \n\nMeasles Resurgence in the U.S. and Beyond\nHumoral and Cellular Immune Responses to SARS-CoV-2 After Natural Infection and Vaccination\nOpportunities and Challenges for Next Generation Sequencing of SARS-CoV-2\nLaboratory Stewardship of Diagnostic Tests within the Clinical Virology Laboratory\nTesting Trends and Guidelines for Screening and Monitoring of HIV Infections\nCRISPR/Cas Gene Editing as a Strategy for Antiviral Therapy: A Potential Cure for HIV-1\nA Physician’s Perspective on the Clinical Utility of Next Generation Sequencing\nCapacity Building Strategies in Dealing with a Global Outbreak of Viral Disease\nOutcome Studies to Evaluate the Clinical Impact of Laboratory Testing\nAssociation Between Enteroviruses and Acute Flaccid Myelitis\nGlobal Challenge of Emerging & Reemerging Viral Infections – A Report from the Tropics\nInfluenza During the COVID-19 Pandemic\nWastewater-based Epidemiology: Public Health Value of Tracking Existing and Emerging Viruses\nThe Quest for a Safe and Effective RSV Vaccine: Is It Nearly Within Reach?\nAn Update on Standardization and Harmonization of Molecular Diagnostics\n\nPlease visit the ASM Clinical Virology Symposium site for more information.
URL:https://globalbiodefense.com/event/2022-asm-clinical-virology-symposium/
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220503
DTEND;VALUE=DATE:20220507
DTSTAMP:20220420T214323Z
CREATED:20220420T213804Z
LAST-MODIFIED:20220420T214323Z
UID:54802-1651536000-1651881599@globalbiodefense.com
SUMMARY:ABSA 2nd Biosecurity Symposium
DESCRIPTION:ABSA International will host the 2nd Biosecurity Hybrid Symposium 3-6 May 2022 in a hybrid virtual and in-person format in Minneapolis\, Minnesota. \nThe hybrid symposium will consist of papers\, presentations\, keynotes\, posters\, valuable networking opportunities\, and in-person exhibits. Attendees may register for the in-person event or the virtual event. \nThe event will gather biosecurity professionals from a wide range of disciplines with varying expertise to share their experiences and knowledge and to learn from each other. The agenda includes themes on biosecurity governance\, implementation\, personnel reliability\, bioeconomy\, biosecurity in DIYbio communities\, biosecurity training\, cyberbiosecurity\, and interactive discussions on lessons learned and public engagement for the future. \nThe symposium will showcase thought-provoking leaders and pioneering researchers from various traditional and non-traditional fields that intersect with biosecurity. A segment on new and emerging topics in biosecurity will also be featured. \nHighlighted sessions include: \n\nBiosecurity: Past\, Present\, and Future: Vibeke Halkjaer-Knudsen\, PhD\, Sandia National Laboratories\, Albuquerque\, NM\nEnhancing Security for Emerging Biotechnologies through Collaboratively Designed Exercises: Julie E. Fischer\, PhD\, CRDF Global\, Arlington\, VA\nPreventing Future Pandemics: The Critical Role of Biosecurity in Global Health Security: Samantha Dittrich\, PhD\, Merrick & Company\, Arlington\, VA\nEnhancing Biosecurity Globally Through Implementation of Personal Reliability Programs: Brittany Linkous\, MS\, Merrick & Company\, Arlington\, VA\nBiosecurity and the Bioeconomy: J. Bradley Dickerson\, PhD\, Sandia National Laboratories\, Albuquerque\, NM\nLab Design Matters: Maria Landron\, DrPH\, Association of Public Health Laboratories (APHL)\, Silver Spring\, MD\nTianjin Biosecurity Guidelines for Codes of Conduct for Scientists: Gigi Kwik Gronvall\, PhD\, Johns Hopkins Center for Health Security\, Baltimore\, MD\nConcentric by Ginkgo: Building a Biosecurity and Public Health Platform for the Present and Future: Brian Renda\, PhD\, Ginkgo Bioworks\, Boston\, MA\nRegional Legal Framework as a Basis and an Enhancer of Biosafety and Biosecurity in the African Union Member States: Jaures Arnaud Noumedem Kenfack\, Africa Centers for Diseases Control and Prevention\, Abuja\, Nigeria\nInfectious Disease as a Security Threat and the Role of Public Health Emergency Management in Biodefense and Biosecurity: A COVID-19 Case Study: Ryan S. Houser\, MS\, MPH\, Tetra Tech\, Parsippany\, NJ\nBiosecurity Capacity Building Through a Biosecurity Champions Fellowship Program in Pakistan: Samreen Sarwar\, M.Phil\, Health Security Partners\, Lahore\, Pakistan\nIdentifying and Avoiding Common Mistakes in Risk and Threat Management: Lauren Richardson\, DVM\, MPH\, Merrick and Company\, Arlington\, VA\nBeyond Training: Using Behavioral Science to Motivate Proactive Biorisk Management: Daniel Greene\, PhD\, Stanford University\, Stanford\, CA\nCommunity Driven Genome Engineering Biosecurity Workshop: Industry Practices\, Resources\, and Opportunities: Beth Vitalis\, Inscripta\, Boulder\, CO\n\nPlease visit ABSA International’s 2nd Biosecurity Symposium website to register.
URL:https://globalbiodefense.com/event/absa-2nd-biosecurity-symposium/
LOCATION:Renaissanc Minneapolis Hotel\, The Depot\, 225 3rd Ave S\, Minneapolis\, MN\, 55401-2524\, United States
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220503T140000
DTEND;TZID=America/New_York:20220503T150000
DTSTAMP:20220420T201056Z
CREATED:20220420T200824Z
LAST-MODIFIED:20220420T201056Z
UID:54789-1651586400-1651590000@globalbiodefense.com
SUMMARY:COVID-19 Testing Toolkit Webinar: University Testing Strategies
DESCRIPTION:Join the Johns Hopkins Center for Health Security’s COVID-19 Testing Toolkit for a webinar where panelists will discuss how Johns Hopkins University developed and implemented its COVID-19 testing strategies for faculty\, staff\, and students \nMODERATOR \nGigi Gronvall\, PhD\, Senior Scholar\, Johns Hopkins Center for Health Security; Lead\, COVID-19 Testing Toolkit and Associate Professor in the Department of Environmental Health and Engineering at the Johns Hopkins Bloomberg School of Public Health \nPANELISTS \nStephen Gange\, PhD\, Professor of Epidemiology in the Johns Hopkins Bloomberg School of Public Health with a joint appointment in the School of Medicine\, and Executive Vice Provost for Academic Affairs\, Johns Hopkins University \nJonathan Links\, PhD\, Professor of Environmental Health and Engineering in the Johns Hopkins Bloomberg School of Public Health \, with joint professorial appointments in the schools of Medicine\, Education\, Engineering\, and Business\, and Vice Provost and Chief Risk Officer\, Johns Hopkins University \nLainie Rutkow\, JD\, PhD\, Professor of Health Policy and Management in the Johns Hopkins Bloomberg School of Public Health with a joint appointment in the School of Medicine\, and Vice Provost for Interdisciplinary Initiatives\, Johns Hopkins University. \nThe moderated discussion will be followed by a Q&A session. Media are invited. \nLearn more about this event and register HERE.
URL:https://globalbiodefense.com/event/covid-19-testing-toolkit-webinar-university-testing-strategies/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:https://jh.zoom.us/webinar/register/WN_I19cGA6FSNWGPHt_6xaYCA
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220504T120000
DTEND;TZID=America/New_York:20220504T133000
DTSTAMP:20220422T200622Z
CREATED:20220422T195642Z
LAST-MODIFIED:20220422T200622Z
UID:54839-1651665600-1651671000@globalbiodefense.com
SUMMARY:Biological Risks and Hazards in the World Today - Special Focus on Russia and Ukraine
DESCRIPTION:An expert panel on Biological Risks and Hazards in the World Today with a Special Focus on Russia and Ukraine will be held on 4 May 2022 via webcast. \nTopics will include the health security environment in the post-Soviet states\, as assessed by the Global Health Security Index of 2019 and 2021\, and the biological risks posed by Russia’s invasion of Ukraine and associated disinformation campaign. \nJessica Bell and Hayley Secerance\, of the Nuclear Threat Initiative\, will discuss health security environment across the post-Soviet states. \nGregory Koblentz of George Mason University will address the evolving biosecurity landscape. \nHon. Andrew Weber of the Council on Strategic Risks and former Assistant Secretary of Defense for the Obama Administration will discuss what we know and what we don’t know about the Russian Federation’s biological and chemical weapons’ program. \nRebecca Katz of Georgetown University and Ian Lipkin of Columbia University round out the event. \nThe webinar will be moderated by Wilmot James. \nPlease visit the Columbia University Institute for Social and Economic Research and Policy (ISERP) Biological Risks and Hazards in the World Today event page to register.
URL:https://globalbiodefense.com/event/iserp-biological-risk-hazards-russia-ukraine/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:https://columbiauniversity.zoom.us/webinar/register/WN_EalzNo1oQw6zWvNG-iWjvA
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220510
DTEND;VALUE=DATE:20220512
DTSTAMP:20220325T162045Z
CREATED:20220325T162045Z
LAST-MODIFIED:20220325T162045Z
UID:54586-1652140800-1652313599@globalbiodefense.com
SUMMARY:FutureTox V: New Technologies to Evaluate Organ-Specific Effects of Drugs and Chemicals
DESCRIPTION:The Society of Toxicology will host FutureTox V: New Technologies to Evaluate Organ-Specific Effects of Drugs and Chemicals on 10-11 May 2022 in Chapel Hill\, North Carolina. \nThe FutureTox series focuses on building the road for 21st-century toxicology and risk assessment practices\, utilizing in vitro data and in silico models for predictive toxicology\, and taking the high-throughput risk assessment paradigm forward to address challenges in implementing the emerging big-data toolbox for risk assessment and regulatory decision-making. \nHighlighted topics of interest include: \n\nModeling environment for organ-specific computational synthesis and integration\nNovel single cell sequencing-based technologies\nIn silico models of organ-specific effects\nFDA\, EPA discussion on future tech and research needs to evaluate organ-specific effects of drugs and chemicals\nFDA\, EPA discussion on opportunities for regulators to use new models and technologies in evaluating organ-specific effects of drugs and chemicals\nNIEHS/NICEATM\, EPA breakout discussion of ‘big data’ stream utilization in toxicology and risk assessment\nAdvantages and barriers to application of new models for evaluating effects of drugs and chemicals on the blood-brain barrier\nPerfused microphysiological systems\nLiver spheroids and micropatterned cultures\nModeling the gut microbiome\nAir-liquid interface models for airway safety assessment\nOpportunities to advance IVIVE with physiological organ-specific models\n\nPlease visit the Society of Toxicology’s FutureTox V website for more information. \n 
URL:https://globalbiodefense.com/event/futuretox-v-new-technologies-to-evaluate-organ-specific-effects-of-drugs-and-chemicals/
LOCATION:UNC Chapel Hill Friday Center\, 100 Friday Center Drive\, Chapel Hill\, NC\, 27599\, United States
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220602T132000
DTEND;TZID=America/New_York:20220602T154500
DTSTAMP:20220601T173444Z
CREATED:20220601T173444Z
LAST-MODIFIED:20220601T173444Z
UID:55587-1654176000-1654184700@globalbiodefense.com
SUMMARY:Future Trends in the Bioeconomy and Changing Life Sciences Research Landscape
DESCRIPTION:The National Academies’ Board on Life Sciences is pleased to present two discussions – Bioeconomy of the Future and Changing Landscape of Life Science Research Laboratories – to explore critical and emerging issues with the bioeconomy and privately-sponsored basic life sciences research. \nThe life sciences research landscape is changing rapidly as new investments in the bioeconomy drive convergence among science and technology fields to develop new products and services\, and as basic research laboratories are established by private investors. \nThe Bioeconomy of the Future will explore: \n\nChanges that have taken place since publication of the National Bioeconomy Blueprint (2012)\, Safeguarding the Bioeconomy (2020)\, and The Bio Revolution: Innovations Transforming Economies\, Societies\, and our Lives (2020)\nImmediate and near-term developments associated with the bioeconomy\nFuture needs for realizing the full potential of the bioeconomy\nOutstanding needs for protecting and promoting the bioeconomy long-term\n\nFeatured Speakers \n\nMary Maxon\, Schmidt Futures\nAndrea Hodgson\, Schmidt Futures\nMichael Chui\, McKinsey & Company\n\nThe Changing Landscape of Life Sciences Research Laboratories will explore: \n\nShifts in the landscape of life sciences research based on the emergence of research institutes funded by for-profit companies\nThe benefits to the shifting life sciences research landscape\nPossible trade-offs related to life sciences research that are conducted at for-profit institutions\nEmerging trends in life science research landscape and how they relate to current and future public policy\nFuture workforce needs and how education might change to support these new institutions\n\nPlease visit the National Academies’ Future Trends in the Bioeconomy and Changing Life Sciences Research Landscape event page for more information.
URL:https://globalbiodefense.com/event/future-trends-in-the-bioeconomy-and-changing-life-sciences-research-landscape/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:https://www.nationalacademies.org/event/06-02-2022/board-on-life-sciences-open-webinar-future-trends-in-the-bioeconomy-and-changing-life-sciences-research-landscape
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220609
DTEND;VALUE=DATE:20220614
DTSTAMP:20240623T192335Z
CREATED:20210925T163351Z
LAST-MODIFIED:20240623T192335Z
UID:49843-1654732800-1655164799@globalbiodefense.com
SUMMARY:ASM Microbe 2022
DESCRIPTION:ASM Microbe 2022 will be held 9-13 June 2022 in Washington\, D.C. \nASM Microbe 2022 will also include a virtual component providing access to scientific programming and accommodating those who are unable or do not wish to attend in-person. Get details on the digital experience. \nAntimicrobial agents and resistance\, biofilms\, HAIs\, diagnostic immunology\, antifungal agents\, and pharmacological studies of antimicrobial agents are just some of the core topics covered in this can’t-miss event. \nHighlighted sessions and topics include: \n\nNGS for Near Real-Time Surveillance and Outbreak Response by Public Health and Clinical Labs\nPublic Health Implications of Fungal Diseases: It’s Time for Action\nUse of Human Organ-on-Chip and Organoid Platforms in Acute Viral Disease\nIn-depth Symposium. AAR14M. One Health Right Now\nTick\, Talk\, Boom: Newly Emerging Tick-Transmitted Disease\nPre-Term and Pediatric Infections: How to Prevent and How to Treat\nCrossing the Threshold: Pros and Cons of Reporting Cycle Threshold Values\nWastewater-based Epidemiology: SARS-CoV-2 and Other Emerging Pathogens\nFungi Enter the AMR Arena\nUsing Protein Structure Prediction Algorithms\nThe Pre-clinical Antimicrobial Pipeline: What is Really New?\nHistopathology of Infectious Diseases for Clinical Microbiologists\nParasites\, Global Health and Novel Pathogens: My Journey as a Clinical Microbiologist\nUpdate on Rapid Diagnostics in Infectious Diseases\nAvoiding Dogmas and Pitfalls in Clinical Parasitology\nAdaptation of Mouse Models for Human Adapted Pathogens\nCurrent Status of Vaccine Research and Development for Clostridioides difficile\nLaboratory diagnostics for invasive fungal infections with a focus on immunocompromised hosts\nI Can’t Take This Anymore–Taxonomic Changes in Microbiology (Can We Find Common Ground?)\nOld Foes\, New Horizons: Updates and Innovations in Malaria and Polio Vaccines\nScience Communication: Combating Vaccine Hesitancy\nChallenging Gram-positive Clinical Cases for Application of New Agents\nMicrobiology in Space: Moving Beyond Low Earth Orbit to the Moon and Mars\nVerification and Validation of Microbiology Tests: Tackling the Who\, What\, When\, Why and HOW?\nBacterial Integration of Host Microbiota Cues Regulate Fitness and Virulence\nThe Pandemic Response in Developing Nations: TB Re-emergence and Other Unexpected Challenge\nDrug Resistance and Diarrheal Disease in the Developing World\nPlastics\, Metals and Other Contaminants as AMR Hotspots and Transporters\nPathogens and Pest Control in Agriculture\nMicrobiomes of Livestock in Food Systems: Emerging Pathogens\, Probiotics and Alternatives to Antibiotics\nNew Agents Discovery Summary Session: Early New Antimicrobial Agents\nMicrobiology and Stewardship Lessons Learned During the COVID-19 Pandemic\n\n Please visit the ASM Microbe website for more information.
URL:https://globalbiodefense.com/event/asm-microbe-2022/
LOCATION:Washington DC Area\, Washington\, DC\, United States
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220619
DTEND;VALUE=DATE:20220624
DTSTAMP:20210226T210720Z
CREATED:20210226T210720Z
LAST-MODIFIED:20210226T210720Z
UID:48681-1655596800-1656028799@globalbiodefense.com
SUMMARY:ISPPD-12 International Symposium on Pneumococci and Pneumococcal Diseases
DESCRIPTION:Discover the latest achievements in the fight against the pneumococcus at the ISPPD-12 International Symposium on Pneumococci and Pneumococcal Diseases 19-23 June 2022 in Toronto. \nThis meeting was originally scheduled for Oct 2020. Given on-going safety concerns for in-person meetings due to COVID-19 during 2020-2021\, the in-person event was ultimately pushed to June 2022. \nThe event brings together professionals in the field to raise global awareness and improve standards of diagnosis\, prevention and treatment. \nHighlighted topics include: \n\nEpidemics\, outbreaks\, and special settings\nPneumococcal epidemiology\nVaccine effect on disease in children\nTrends in non-vaccine serotypes\nMathematical modeling\nDiagnosis and diagnostic assays\nAntimicrobial resistance\nConventional and molecular microbiology\nTreatment of pneumonia and pneumococcal disease\nGenetic sequencing\nPneumococcal colonization\nAdult vaccination strategies\nIndirect effects of paediatric programmes on disease in adults\nPneumococcal disease in persons with high-risk conditions\nPneumococcal vaccines in development\nCOVID effects on pneumonia and pneumococcal disease burden\nEffects of COVID on pneumoccoccal vaccine programmes\nManagement of community acquired pneumonia in the time of COVID\nEmerging data on SARS-CoV2 and pneumococcus interaction\n\nPlease visit the ISPPD-12 website for more information on how to participate.
URL:https://globalbiodefense.com/event/isppd-12-international-symposium-on-pneumococci-and-pneumococcal-diseases/
LOCATION:Sheraton Centre Toronto Hotel\, 123 Queen St W\, Toronto\, Ontario\, M5H 2M9
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220629T120000
DTEND;TZID=America/New_York:20220629T170000
DTSTAMP:20220622T153805Z
CREATED:20220622T153805Z
LAST-MODIFIED:20220622T153805Z
UID:55703-1656504000-1656522000@globalbiodefense.com
SUMMARY:USG Policies for the Oversight of Life Sciences Dual Use Research of Concern
DESCRIPTION:The purpose of this meeting is to gather feedback from stakeholders about their experiences implementing these policies\, the effect of these policies in terms of achieving their stated goals\, the overarching definition of DURC\, and possible alternative approaches for the oversight and responsible conduct of DURC. \nThis feedback will also be used to inform the discussions of the National Science Advisory Board for Biosecurity (NSABB) in fulfillment their current charge to evaluate and analyze the DURC policies. \nRegistration is not required to view the webcast. \nREAD MORE: Dual Use Research of Concern: NIH to Host Stakeholder Engagement Meeting on Oversight Policies
URL:https://globalbiodefense.com/event/usg-policies-for-the-oversight-of-life-sciences-dual-use-research-of-concern/
CATEGORIES:Conference,Government Hosted
LOCATION:https://osp.od.nih.gov/event/virtual-stakeholder-engagement-meeting-on-usg-policies/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220727
DTEND;VALUE=DATE:20220731
DTSTAMP:20220601T174333Z
CREATED:20220601T174333Z
LAST-MODIFIED:20220601T174333Z
UID:55589-1658880000-1659225599@globalbiodefense.com
SUMMARY:Toxins 2022 International Conference
DESCRIPTION:TOXINS 2022 will be held July 27-30\, 2022\, at the New Orleans Marriott in New Orleans\, Louisiana.\nThis is the foremost gathering for the latest developments in the basic science and clinical applications of botulinum and other neurotoxins. \nThe scientific program—presented by the world’s experts in their respective fields—will be of interest to basic scientists and clinicians in the fields of neurology\, physical medicine and rehabilitation\, dermatology\, aesthetic medicine\, ophthalmology\, otolaryngology\, urology\, gastroenterology\, and pain management. \nThe TOXINS conference is hosted by the International Neurotoxins Association. Due to restrictions associated with the global COVID-19 pandemic\, TOXINS 2021: Basic Science and Clinical Aspects of Botulinum and Other Neurotoxins\, was held as a virtual event 16-17 January 2021. The conference was a tremendous success with 1101 clinicians and scientists representing 63 countries participating. The event was also made available on demand and was accessed by 328 participants. \nJoin researchers and stakeholders at the TOXINS 2022 event in New Orleans. \n 
URL:https://globalbiodefense.com/event/toxins-2022-international-conference/
LOCATION:New Orleans Marriott\, 555 Canal Street\, New Orleans\, LA\, 70130\, United States
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20220831T120000
DTEND;TZID=America/Chicago:20220831T130000
DTSTAMP:20220829T173614Z
CREATED:20220829T173614Z
LAST-MODIFIED:20220829T173614Z
UID:56247-1661947200-1661950800@globalbiodefense.com
SUMMARY:Monkeypox: Updates in Evaluation and Management
DESCRIPTION:Discuss the current landscape of Monkeypox in the U.S and infection prevention considerations for evaluation and management in healthcare settings. \nDescribe the clinical presentation in ambulatory and inpatient settings\, as well as the role of supportive and antiviral treatments. \nThis NETEC webinar series presentation will bring together health care practitioners from Massachusetts General Hospital\, Cedars-Sinai\, and NYC Health + Hospitals to share their first-hand experiences caring for patients with monkeypox. Panelists will discuss the current landscape of monkeypox\, infection prevention in health care settings\, and the role of supportive and antiviral treatments in patient care. Panelists will also answer audience questions submitted during webinar registration. \nPANELISTS \nJonathan Grein\, MD\nDirector of Hospital Epidemiology\,\nCedars-Sinai Medical Center\, Los Angeles \nErica S. Shenoy\, MD\nAssociate Chief\, Infection Control Unit\nMedical Director\, Regional Emerging Special Pathogens Treatment Center\nMassachusetts General Hospital \nKevin L. Ard\, MD\, MPH\nDirector\, Sexual Health Clinic\,\nMassachusetts General Hospital\nAssistant Professor\, Harvard Medical School \nPlease visit the NETC website to register for Monkeypox: Updates in Evaluation and Management.
URL:https://globalbiodefense.com/event/monkeypox-updates-in-evaluation-and-management/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:https://unmc.zoom.us/webinar/register/WN_hETaz1ecTRuqvb_mKoemtg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220912
DTEND;VALUE=DATE:20220914
DTSTAMP:20220830T001753Z
CREATED:20220830T001521Z
LAST-MODIFIED:20220830T001753Z
UID:56267-1662940800-1663113599@globalbiodefense.com
SUMMARY:Presidential Advisory Council on Combating Antibiotic Resistant Bacteria
DESCRIPTION:The 21st Presidential Advisory Council on Combating Antibiotic Resistant Bacteria (PACCARB) public meeting is tentatively being planned as an in-person event on September 12 and September 13\, 2022. The meeting will focus on pandemic preparedness and AMR policy. \nHighlighted topics include: \n\nUnderstanding the Human Diagnostic Communication Network (Labs\, Public Health Departments\, and Providers)\nInfection Prevention and Control for Resistant Pathogens during a Medical Surge\nLeveraging the Existing Pipeline of Available Vaccines and Therapeutics while Developing New AMR MCMs (Human)\nDeveloping New Human Diagnostics in an Emergency Situation: What’s Expected\, Needed\, and How We Get What We Need\nA Pandemic Response from a Global Perspective\nThe Agricultural Workforce: Human Health Risk and the Role of Workers as Vectors of Transmission\nThe Role of Associations in Pandemic Response and Dissemination of Information\nImpact of a Public Health Emergency on Human Antibiotic Stewardship Practices\nDiagnosing Fungal Infections and Resistance with our Current Diagnostic Capacity\nThe Role of Diagnostics in Herds: Availability\, Challenges\, and How They’re Used\nThe Federal Strategy for Animal Surveillance\, Information Sharing\, and Disseminating Guidance\nRecognizing the Pandemic: Identifying the “AMR Pandemic” within the Pandemic and Disseminating Information and Guidance\nLeveraging Current Human Antibiotic-Use-Monitoring for AMR Pandemic Surveillance\nRecognizing the Pandemic: Producer Surveillance Methods and Identifying Secondary AMR infections in Animal Production\nDevelopment of New Animal Vaccines and Understanding Federal Regulations\nUnderstanding the Animal Diagnostic Communication Network (Labs\, Producers\, and Veterinarians)\nSources of Environmental Contamination and the Potential for Surveillance\n\nThis meeting is open to the public. Members of the public can choose to attend in-person (attendance will be limited) or view the meeting via webcast. Please visit the HHS 21st Presidential Advisory Council on Combating Antibiotic Resistant Bacteria (PACCARB) website to register.
URL:https://globalbiodefense.com/event/paccarb-public-meeting-presidential-advisory-council-on-combating-antibiotic-resistant-bacteria/
LOCATION:Tysons Corner Marriott\, 8028 Leesburg Pike\, Tysons Corner\, VA\, 22182-2719\, United States
CATEGORIES:Conference,Government Hosted
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220920
DTEND;VALUE=DATE:20220925
DTSTAMP:20220829T233259Z
CREATED:20220829T233259Z
LAST-MODIFIED:20220829T233259Z
UID:56263-1663632000-1664063999@globalbiodefense.com
SUMMARY:21st Congress of the International Society for Human and Animal Mycology
DESCRIPTION:The 21st Congress of the International Society for Human and Animal Mycology will be \nHighlighted topics of interest include: \n\nVeterinary relevant and zoonotic fungal groups\nDevelopment of WHO priority pathogens list of public health importance\nAMR fungal infections global burden: surveillance challenges\, gap & opportunities: WHO GLASS pilot\nUnraveling the genetic determinants of virulence in Cryptococcus\nWHO first antifungals clinical & preclinical pipeline review\nDiagnostic Rounds Interactive session for diagnosis of emerging and re-emerging fungal infections\nAntifungal activity of antimicrobial synthetic peptides against Candida species of public health importance\nHigh rate of chronic pulmonary aspergillosis in active TB patients in Indonesia with GeneXpert positive?\nDevelopment of a breath-based diagnostic for valley fever\, an endemic fungal pneumonia\nInvestigation of in vitro antifungal susceptibility testing and genetic diversity of clinical isolates of Trichophyton benhamiae and Trichophyton eriotrephon in Iran\nShould we continue to use conventional doses of candins for all ICU patients?\nParadigm shift in the epidemiology of invasive fungal infections during COVID-19 pandemics\nCryptococcus qPCR assays: the future for routine mycology labs and clinical trials dealing cryptococcosis\nEvaluation of new tools for the diagnosis of histoplasmosis\nAgrochemicals potentiate multidrug resistance and alter virulence in Cryptococcus neoformans via hitch-hiking effect of aneuploidy\nFuture of molecular typing in fungi\nStanding Up FungiNet: Genomic epidemiology and surveillance of fungal diseases\nStandardization of diagnostic mycology laboratories\nWhy sporotrichosis and Paracoccidioidomycosis should be considered neglected tropical disease\n\nPlease visit the ISHAM website to register for the 21st Congress of the International Society for Human and Animal Mycology meeting.
URL:https://globalbiodefense.com/event/21st-congress-of-the-international-society-for-human-and-animal-mycology/
LOCATION:Hotel de Ashok\, 50\, Niti Marg\, Diplomatic Enclave\, New Delhi\, Chanakyapuri\, 110021\, India
CATEGORIES:Conference
ORGANIZER;CN="International Society for Human and Animal Mycology (ISHAM)":MAILTO:isham2022@congresscare.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220921
DTEND;VALUE=DATE:20220923
DTSTAMP:20220420T212311Z
CREATED:20220420T212042Z
LAST-MODIFIED:20220420T212311Z
UID:54799-1663718400-1663891199@globalbiodefense.com
SUMMARY:Scientific Advisory Committee on Alternative Toxicological Methods (SACATM) Meeting
DESCRIPTION:The Scientific Advisory Committee on Alternative Toxicological Methods will meet 21-22 September 2022. \nThis is a Save-the-Date posting. Further details will be made available at the National Toxicology Program website closer to the meeting date.
URL:https://globalbiodefense.com/event/scientific-advisory-committee-on-alternative-toxicological-methods-sacatm-meeting/
CATEGORIES:Conference,Government Hosted
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220921T120000
DTEND;TZID=America/New_York:20220921T130000
DTSTAMP:20220921T172921Z
CREATED:20220921T172727Z
LAST-MODIFIED:20220921T172921Z
UID:56416-1663761600-1663765200@globalbiodefense.com
SUMMARY:Virtual Town Hall Series - Monkeypox Test Development and Validation
DESCRIPTION:The U.S. Food and Drug Administration (FDA) will host a virtual town hall for monkeypox test developers on 21 September 2022. The purpose of these town halls is to help answer technical questions about the development and validation of tests for monkeypox. \nThe FDA plays a critical role in protecting the United States from threats such as emerging infectious diseases\, including monkeypox . The FDA is committed to providing timely guidance to support response efforts to this public health emergency. \nThe guidance\, Policy for Monkeypox Tests to Address the Public Health Emergency\, includes policies specific to this public health emergency. \nThe FDA hosted a webinar on September 14\, 2022\, to discuss highlights of and answer questions about the final guidance. The presentation\, printable slides\, and transcript from that webinar are available at CDRH Learn under “Specialty Technical Topics”\, sub-section “Public Health Emergencies.”
URL:https://globalbiodefense.com/event/virtual-town-hall-series-monkeypox-test-development-and-validation/
CATEGORIES:Conference,Government Hosted
LOCATION:https://fda.zoomgov.com/j/1612083563?pwd=NklWOE1jUlU2dUVlNWtvQTNkdTM5UT09#success
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20221004
DTEND;VALUE=DATE:20221008
DTSTAMP:20220420T231323Z
CREATED:20220420T231135Z
LAST-MODIFIED:20220420T231323Z
UID:54819-1664841600-1665187199@globalbiodefense.com
SUMMARY:ESCMID-ASM Drug Development to Meet the Challenge of AMR
DESCRIPTION:The 2022 ESCMID/ASM Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance is scheduled to take place Oct. 4-7\, 2022 in Dublin\, Ireland. \nAntimicrobial drug resistance (AMR) is an urgent global health problem. New antimicrobial drug development is increasingly viewed as a priority by national and international bodies. Co-sponsored by the American Society for Microbiology (ASM) and the European Society for Clinical Microbiology and Infectious Diseases (ESCMID)\, this multidisciplinary meeting will address the challenges\, opportunities and current requirements for antimicrobial drug development to address antimicrobial resistance. \nAbstracts can be submitted until 27 June 2022 in the following categories: \n\nDrug discovery\nDrug development\nNovel therapeutics\nPreclinical development\nNew antibacterial classes\nNon-traditionals\nClinical development\nStewardship\n\nPlease visit the ESCMID website to register for the Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance 2022.
URL:https://globalbiodefense.com/event/escmid-asm-drug-development-to-meet-the-challenge-of-amr/
LOCATION:Dublin\, Ireland\, Dublin\, Ireland
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20221019
DTEND;VALUE=DATE:20221022
DTSTAMP:20220922T140954Z
CREATED:20220922T140800Z
LAST-MODIFIED:20220922T140954Z
UID:56448-1666137600-1666396799@globalbiodefense.com
SUMMARY:GSRS22 - 12th Global Summit on Regulatory Science
DESCRIPTION:GSRS22: The 12th Global Summit on Regulatory Science will be held from 19-21 October 2022 in Singapore. \nConvening under a theme of “Advances in Nanotechnology for Food and Medical Products: Innovations\, Safety and Standards”. the Summit will highlight topics including: \n\nNanomaterials for Gene Delivery\nNanotechnology in Agri-Products\nEmerging Nanomaterial Contaminants in Food\nGeneric Medical Products Containing Nanomaterial\nRole of Nanotechnology in Precision Medicine\nInnovation in Nanotechnology for Food\n\nThe Global Summit is free to attend\, but registration is required to attend the conference. \nThis event is being co-hosted by Singapore Food Agency (SFA) and the Global Coalition for Regulatory Science Research (GCRSR). \nPlease visit the GSRS22 website to register.
URL:https://globalbiodefense.com/event/gsrs22-12th-global-summit-on-regulatory-science/
LOCATION:Orchard Hotel Singapore\, 442 Orchard Road\, Singapore\, 238879\, Singapore
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20221027T140000
DTEND;TZID=America/New_York:20221027T150000
DTSTAMP:20221025T173153Z
CREATED:20221025T173153Z
LAST-MODIFIED:20221025T173153Z
UID:56589-1666879200-1666882800@globalbiodefense.com
SUMMARY:Public Health Workforce Calculator: Staffing up to Achieve Foundational Services
DESCRIPTION:In 2021\, an analysis of the public health workforce found that state and local governmental public health departments need an 80% increase in their workforce to provide a minimum set of public health services to the nation. In response to this gap\, the Public Health National Center for Innovations at PHAB\, de Beaumont Foundation\, and the Centers for Disease Control and Prevention’s Center for State\, Tribal\, Local and Territorial Support developed the Public Health Workforce Calculator to aid local health departments in estimating staffing needs to provide the Foundational Public Health Services in their community. Join us on October 27th at 2PM ET to learn more about the Calculator and how it can contribute to workforce staffing needs and planning for public health funding. \nWebinar Objectives\n– Describe how the analysis was used to successfully build support for health departments\n– Explain the intended use of the recently released Public Health Workforce Calculator.\n– Demonstrate how to use the Calculator\, including identifying the Calculator’s best use cases.
URL:https://globalbiodefense.com/event/public-health-workforce-calculator-staffing-up-to-achieve-foundational-services/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:https://us02web.zoom.us/webinar/register/1316650817717/WN_273HybPhTfOA1Df_brsQNQ
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20221111
DTEND;VALUE=DATE:20221118
DTSTAMP:20220620T202418Z
CREATED:20220620T202418Z
LAST-MODIFIED:20220620T202418Z
UID:55678-1668124800-1668729599@globalbiodefense.com
SUMMARY:70th IAEM Annual Conference & EMEX
DESCRIPTION:The 70th IAEM Annual Conference & EMEX will be held 11-17 November 2022 in Savannah\, Georgia. \nThe program features more than 150 speakers providing plenaries and breakout sessions under the umbrella theme\, “Emergency Management Unmuted.” In addition\, All DHS/FEMA pre-/post-conference training courses\, the IAEM Leadership Symposium\, IAEM K-12 Workshop\, and the Ascenttra Advanced Exercise Design Course are complimentary for those registered under the full and student registration rates. \nHighlighted topics\, sessions and courses include: \n\nIntermediate Incident Command System for Expanding Incidents\nEvolving NIMS to Protect Information and Technology and Communications Used at Ad-hoc and Temporary Vaccination and Hospital Sites\nLeadership Symposium: Preparing for Disaster Resilience\nCERT Worldwide: The State of Disaster Volunteerism in Latin America\nAn Examination of Current Requirements for Expansion of Nuclear Emergency Support Teams (NEST)\nErosion of Trust: Impacts of Mis and Dis Information to Emergency Management\nHealthcare Caucus Emergency Managers Symposium: Collaborating for the Future\nEmbedding Meteorologists into Emergency Operations\nEvidence-Building in Emergency Management: Expanding Efforts to Measure the Effectiveness of Preparedness Investments\nHomeland Security Exercise and Evaluation Program Training Course\nCrisis Leadership and Decision Making\nAfter the Rumbling Stops … Initiating “Unmuted” Transportation Disaster Response\nK-12 Pre Conference Workshop – Resilient Communities\nEmergency Management during Political Unrest: Lessons from International Medical Organizations and Anecdotes from Yemen\, Syria\, and Afghanistan\nIntroduction to Disaster Recovery Public Assistance Programs\nStrengthening County (Local) Tactical Emergency Animal Shelter Plans: Collaboration Between Texas A and M VET and County EM Coordinators\nMitigation Assessment Team (MAT) Workshop\nUniv. and Colleges E.M. Practitioners Symposium\nRe-Imagining Emergency Response for Children and Families\nCommunity Preparedness for Cyber Incidents\nAEM / CEM Preparatory Course\n\nLearn more and register online at the IAEM Annual Conference website.
URL:https://globalbiodefense.com/event/70th-iaem-annual-conference-emex/
LOCATION:Savannah International Trade and Convention Center\, 1 International Drive \, Savannah\, GA\, 31402\, United States
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230306
DTEND;VALUE=DATE:20230309
DTSTAMP:20220208T205747Z
CREATED:20210925T003746Z
LAST-MODIFIED:20220208T205747Z
UID:49804-1678060800-1678319999@globalbiodefense.com
SUMMARY:Third International Summit on Human Genome Editing
DESCRIPTION:The Third International Summit on Human Genome Editing will be held March 6-8\, 2023 in London\, UK. \nThe event is being organized as a collaborative activity of the U.S. National Academy of Sciences and the U.S. National Academy of Medicine\, the U.K.’s Royal Society and Academy of Medical Sciences\, and The World Academy of Sciences.  It will bring together leading experts to examine the potential risks and benefits of genome editing technologies and the significant ethical and societal issues associated with advances in human genome editing research. \nThe Summit also address the recent report from the International Commission on the Clinical use of Heritable Human Genome Editing and the WHO Expert Advisory Committee on Developing Global Standards for Governance and Oversight of Human Genome Editing report. \nFurther information and details on how to access the Summit will be released closer to the time.
URL:https://globalbiodefense.com/event/third-international-summit-on-human-genome-editing/
LOCATION:Crick Institute\, 1 Midland Road\, London\, NW1 1AT\, United Kingdom
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230425
DTEND;VALUE=DATE:20230427
DTSTAMP:20230421T193514Z
CREATED:20230421T174138Z
LAST-MODIFIED:20230421T193514Z
UID:56972-1682380800-1682553599@globalbiodefense.com
SUMMARY:APEC Medical Product Supply Chain Resilience Dialogue
DESCRIPTION:FDA and United States Pharmacopeia (USP) are cosponsoring the Asia-Pacific Economic Cooperation (APEC) Medical Product Supply Chain Dialogue. This program aims to accelerate APEC and global efforts to strengthen the resilience of global medical product supply chains. This meeting will bring international medical product regulators\, multilateral organization representatives\, and industry and academic professionals together\, to discuss public health priorities\, the impact of the COVID-19 pandemic on supply chains\, and why the APEC Supply Chain Security ToolkitExternal Link Disclaimer continues to be a valuable tool to stakeholders. \nThis event is open to the public and free of cost. \nTopics will include: \n\nAPEC Roadmap to promote global medical product quality and supply chain security\nIdentifying vulnerabilities in the upstream supply chain\nMitigating and managing risks in raw material quality and supply chain security\nManufacturing solutions to strengthen global supply chain resilience\nExperiences strengthening quality assurance in the Asia Pacific\nSafeguarding patients from impurities in the drug supply chain\nThe supply chain imperative to fight AMR\nSecuring the downstream supply chain – good distribution practices & post-marketing surveillance\nSecuring the downstream supply chain – internet pharmacies\n\nPlease visit the APEC Medical Product Supply Chain Dialogue event website to register.
URL:https://globalbiodefense.com/event/apec-medical-product-supply-chain-resilience-dialogue/
LOCATION:USP Rockville\, 12601 Twinbrook Parkway\, Rockville\, MD\, 20852\, United States
CATEGORIES:Conference,Government Hosted
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2023/04/apec-medical-supply-chain-resilience.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230507
DTEND;VALUE=DATE:20230511
DTSTAMP:20230422T170026Z
CREATED:20230421T232418Z
LAST-MODIFIED:20230422T170026Z
UID:57016-1683417600-1683763199@globalbiodefense.com
SUMMARY:ABRF 2023 Annual Meeting | Association of Biomolecular Resource Facilities
DESCRIPTION:The Annual Meeting of the Association of Biomolecular Resource Facilities (ABRF 2023) will be held 7-10 May 2023 in Boston\, Massachusetts. \nHighlighted topics and presentations include: \n\nBusiness Skills for Core Facility Directors\, Managers and Administrators\nAdvancing Single Cell in Core Laboratories\nImplementing Spatial Transcriptomics in Core Facilities\nUsing R/R-Studio for reproducible data analysis and visualization\nSpatial Biology for Shared Research Laboratories\nGenome Editing Cores and Best Practices\nSample Preparation for Single Cell Genomics\nNon-Biological Core Facilities and Their Place within ABRF\nDigital PCR–applications\, challenges\, and use in a core setting\nNew Sequencers and Evolving Next Generation Sequencing Landscape\nWhat Do We Hand Over When an Analysis Is Finished? A spectrum-style discussion\nCell Sorting Technology Acquisition in the SRL: Evaluation\, Integration and Deployment to Users\nUpdates from the Microbiome and Metagenomics\, Genome Engineering\, and Genomics Research Groups\n\nPlease visit the ABRF 2023 Annual Meeting site for more information and to register.
URL:https://globalbiodefense.com/event/abrf-2023-annual-meeting-association-of-biomolecular-resource-facilities/
LOCATION:Sheraton Boston Hotel\, 39 Dalton Street\, Boston\, MA\, 02199\, United States
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230611
DTEND;VALUE=DATE:20230616
DTSTAMP:20230422T155708Z
CREATED:20230422T155251Z
LAST-MODIFIED:20230422T155708Z
UID:57028-1686441600-1686873599@globalbiodefense.com
SUMMARY:The Protein Phosphorylation Conference
DESCRIPTION:The Protein Phosphorylation Conference will be held 11-15 June 2023 in Steamboat Springs\, Colorado. This Federation of American Societies for Experimental Biology (FASEB) Science Research Conference (SRC) focuses on new discoveries and techniques regarding the role of protein phosphorylation in health and disease. \nThe conference brings together an interdisciplinary group of scientists representing academia and industry who study and conduct research on protein phosphorylation. \nProgram Details \nThe program focuses on kinase signaling through canonical and non-canonical modes and network regulation of signaling outputs. We will explore how they provide insight critical to our understanding of kinases and kinase pathways underlying normal physiology and disease progression\, and the translation of this information in the design of improved therapeutic strategies. \nConference sessions will present the latest research findings and foster engaging discussion on: \n\nStructural regulation of kinases\nOptogenetic and chemical genetic approaches to kinase and phosphatase networks\nConcepts in drug resistance\nKinase allostery and molecular scaffolds\nSignaling dynamics\nSystems and mathematical biology of phosphorylation networks\n\nThe conference covers eight sessions\, with 16 talks selected from abstracts\, and two poster sessions. \nPlease visit FASEB’s Protein Phosphorylation Conference site for more information and to register.
URL:https://globalbiodefense.com/event/the-protein-phosphorylation-conference/
LOCATION:The Steamboat Grand Resort\, 2300 Mt Werner Circle\, Steamboat Springs\, CO\, 80487\, United States
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230611
DTEND;VALUE=DATE:20230616
DTSTAMP:20230422T163234Z
CREATED:20230422T163234Z
LAST-MODIFIED:20230422T163234Z
UID:57038-1686441600-1686873599@globalbiodefense.com
SUMMARY:Signal Transduction in the Immune System Conference 2023
DESCRIPTION:The Signal Transduction in the Immune System Conference will be held 11-15 June 2023 in Palm Springs\, California. \nFirst convened in 2000\, this FASEB Science Research Conference (SRC) showcases recent advances in the understanding of signal transduction mechanisms that control immune responses in both health and disease. \nThe conference provides a forum for a diverse community of scientists across all career stages to share and discuss their research and to develop new cross-disciplinary collaborations. It is also recognized as one of the best meetings in the immunology field for trainees to present their work and network. \nProgram Details\nThe conference catalyzes new ideas and the use of interdisciplinary approaches for the development of novel therapeutics to treat inflammatory and autoimmune disorders\, cancer\, and immunodeficiency. \nConference sessions will present the latest research and foster discussion on: \n\nInnate Immune Cell Sensing\nLeukocyte Adhesion and Migration\nLymphocyte Signaling\nSignaling and Effector Function\nImmune Signaling in Health and Disease\n\nThe conference features 35 talks with ten short talks selected from submitted abstracts. New this year are two Lightning Sessions – 20 one-minute talks – that will allow trainees to highlight their poster session presentations selected from abstracts. \nThe program also includes a Meet-The-Expert session\, “Networking in Academia and Industry; When\, What\, How?” and a Career Development Workshop\, “Science Policy and Community Engagement.” \nPlease visit FASEB’s Signal Transduction in the Immune System Conference site for more information and to register.
URL:https://globalbiodefense.com/event/signal-transduction-in-the-immune-system-conference-2023/
LOCATION:Omni Rancho Las Palmas Resort and Spa\, 41000 Bob Hope Drive\, Palm Springs\, CA\, 92270\, United States
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230618
DTEND;VALUE=DATE:20230621
DTSTAMP:20230422T165944Z
CREATED:20230422T165728Z
LAST-MODIFIED:20230422T165944Z
UID:57043-1687046400-1687305599@globalbiodefense.com
SUMMARY:AMP 2023 Europe Congress | Association for Molecular Pathology
DESCRIPTION:The Association for Molecular Pathology (AMP) 2023 Europe Congress will take place 18-20 June 2023 in Milan\, Italy. \nThe AMP Europe Congress will bring together a network of more than 300+ molecular professionals and representatives of the diagnostics industry to educate healthcare practitioners and to advance the value of molecular laboratories in providing high quality patient care around the world. This multi-disciplinary scientific program will showcase molecular diagnostics with clinical applications in infectious diseases\, oncology (solid tumors\, hematopathology)\, genetics (congenital\, heritable)\, and informatics. \nHighlighted presentations include: \n\nThe Role of the -omics in Microbiology and in Infectious Disease Control (SIPMeT)\nEvaluation of SARS-CoV-2 genomic mutations potentially conferring resistance to antiviral drugs in viral populations isolated from untreated SARS-CoV-2-infected subjects\nArtificial Intelligence in Genomic Diagnostics\nLaboratory Strategies for Survival during the Pandemic\nMind the Gap: Advances in Immunology and Diseases\nNavigating the EU’s In Vitro Diagnostic Regulation\nKeeping pace with the homologous recombination deficiency testing landscape\nEvaluation of a Meta-Genomics Next-Generation sequencing (MNGS) assay with novel host Depletion Method for Pathogen Identification in Sepsis patients\n\nPlease visit the AMP 2023 Europe Congress website for more information and to register.
URL:https://globalbiodefense.com/event/amp-2023-europe-congress-association-for-molecular-pathology/
LOCATION:Hotel NH Milano Congress Centre\, Strada 1 Milanofiori\, Assago MI\, Italy
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230624
DTEND;VALUE=DATE:20230629
DTSTAMP:20230422T161944Z
CREATED:20230422T161944Z
LAST-MODIFIED:20230422T161944Z
UID:57033-1687564800-1687996799@globalbiodefense.com
SUMMARY:Worm23 - International C. elegans Conference
DESCRIPTION:The premier meeting for C. elegans researchers will be held 24-28 June 2023 in Glasgow\, Scotland. \nHundreds of presentations cover the full diversity of C. elegans investigations\, including genetics\, molecular biology\, cell biology\, development\, immunology\, physiology\, neuroscience\, evolution\, and more. \nA virtual attendance option is available in addition to the in-person meeting. Virtual participant registration fees will be waived for scientists who are full-time residents of countries with low- and middle-income economies. \nPlease visit the Genetics Society of America 24th International C. elegans Conference website for more information and to register.
URL:https://globalbiodefense.com/event/worm23-international-c-elegans-conference/
LOCATION:Scottish Event Campus\, Exhibition Way\, Glasgow\, Scotland\, G3 8YW\, United Kingdom
CATEGORIES:Conference
ORGANIZER;CN="Genetics Society of America":MAILTO:society@genetics-gsa.org
END:VEVENT
END:VCALENDAR